Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- REGULATORY NEWS IN BRIEF
October 22, 2001
- Abbereviationon of the week
October 22, 2001
- Not to Expect Gov't to Adopt ATP Soon: Mr Butler of PhRMA -1-
October 22, 2001
- Benefits of INNOVA2000 Explained: GE Yokogawa Seminar
October 22, 2001
- Not to Expect Gov't to Adopt ATP Soon: Mr Butler of PhRMA -2-
October 22, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 22, 2001
- Mitsubishi Pharma Establishes Subsidiaries in US, UK
October 22, 2001
- Industry Expresses Opinions on Pricing of Medical Devices: Chuikyo
October 22, 2001
- Losses Reported by 19 of 93 FJPWA Member Wholesalers
October 22, 2001
- GE Marquette Medical Systems: Ultra-small ECG Recorder "SEER Light"
October 22, 2001
- BUSINESS NEWS IN BRIEF -1-
October 22, 2001
- Hac Kimisawa: Half-year Ordinary Profits Up 13.8%
October 22, 2001
- BUSINESS NEWS IN BRIEF -2-
October 22, 2001
- Sugi Yakkyoku: Sales, Profits Up Over 30% in First Half
October 22, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
October 22, 2001
- OTC NEW IN BRIEF
October 22, 2001
- NOTICE
October 22, 2001
- Usefulness of Aspirin Underlined: Dr Hennekens
October 22, 2001
- NHI Price Ceiling to Be Set: Reform Proposal -1-
October 22, 2001
- DIAGNOSTIC NEWS IN BRIEF
October 22, 2001
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…